source
- Nobel Prize honors optogenetics pioneers; Roche licenses Alector’s Parkinson’s enzyme therapyThe Nobel Committee awarded this year’s Physiology or Medicine prize to three scientists whose work created the field of optogenetics. Their discoveries of a light‑sensing protein in algae and its…
- Shionogi to acquire Texas-based IntraBio for $2 billion, adding marketed rare-disease drug AqneursaShionogi announced Monday it will buy IntraBio, a Texas biotech, for $2 billion in cash, making IntraBio a wholly owned subsidiary of its U.S. division. The deal gives Shionogi ownership of Aqneur…